Novo Nordisk A/S (NYSE:NVO)
| 158.07 Delayed Data As of Jun 09 |  -1.38 / -0.87%Today’s Change | 95.02 Today|||52-Week Range 172.97 | +16.79% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 16.0B | 16.6B | 16.9B | 17.7B | |
| Cost of Goods Sold | 2.1B | 2.2B | 2.3B | 2.4B | ||
| Depreciation And Amortization | 387.4M | 393.1M | 435.2M | 602.9M | ||
| Operating Expenses | Gross Income | 13.5B | 13.9B | 14.2B | 14.7B | |
| General Expenses | 6.7B | 6.8B | 6.9B | 7.4B | ||
| Other Operating Expenses | 0.00 | 0.00 | -1.7M | 0.00 | ||
| Research And Development | 1.9B | 2.0B | 2.0B | 2.1B | ||
| Total Operating Expenses | 9.1B | 9.4B | 9.6B | 10.4B | ||
| Non-Operating Expenses | Operating Income | 6.8B | 7.2B | 7.3B | 7.3B | |
| Extraordinary Credit | 0.00 | 0.00 | 91.7M | -- | ||
| Extraordinary Charge | -848.2M | -116.1M | -47.3M | -252.0M | ||
| Interest Expense On Debt | 21.9M | 22.2M | 24.0M | 24.9M | ||
| Equity In Earnings | 2.1M | 3.6M | 2.1M | 1.9M | ||
| Other Expenses | 447.8M | 63.9M | 34.0M | 490.8M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 6.4B | 7.1B | 7.4B | 7.5B | |
| Income Taxes | -1.3B | -1.5B | -1.6B | -1.4B | ||
| Net Income | 5.2B | 5.6B | 5.8B | 6.1B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.6B | 2.5B | 2.5B | 2.4B | |
| Shares To Calculate EPS Diluted | 2.6B | 2.5B | 2.5B | 2.4B | ||
| Earnings Per Share | EPS | $2.01 | $2.22 | $2.34 | $2.53 | |
| EPS Diluted | $2.00 | $2.22 | $2.33 | $2.52 | ||